BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18043718)

  • 1. ALS predisposition modifiers: knock NOX, who's there? SOD1 mice still are.
    Valdmanis PN; Kabashi E; Dion PA; Rouleau GA
    Eur J Hum Genet; 2008 Feb; 16(2):140-2. PubMed ID: 18043718
    [No Abstract]   [Full Text] [Related]  

  • 2. Redox modifier genes in amyotrophic lateral sclerosis in mice.
    Marden JJ; Harraz MM; Williams AJ; Nelson K; Luo M; Paulson H; Engelhardt JF
    J Clin Invest; 2007 Oct; 117(10):2913-9. PubMed ID: 17853944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model.
    Harraz MM; Marden JJ; Zhou W; Zhang Y; Williams A; Sharov VS; Nelson K; Luo M; Paulson H; Schöneich C; Engelhardt JF
    J Clin Invest; 2008 Feb; 118(2):659-70. PubMed ID: 18219391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swelling and vacuolisation of mitochondria in transgenic SOD1-ALS mice: a consequence of supranormal SOD1 expression?
    Jaarsma D
    Mitochondrion; 2006 Feb; 6(1):48-9; author reply 50-1. PubMed ID: 16410057
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
    Jonsson PA; Ernhill K; Andersen PM; Bergemalm D; Brännström T; Gredal O; Nilsson P; Marklund SL
    Brain; 2004 Jan; 127(Pt 1):73-88. PubMed ID: 14534160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
    Oh YK; Shin KS; Yuan J; Kang SJ
    J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.
    Urushitani M; Sik A; Sakurai T; Nukina N; Takahashi R; Julien JP
    Nat Neurosci; 2006 Jan; 9(1):108-18. PubMed ID: 16369483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
    Turner BJ; Lopes EC; Cheema SS
    J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ALS models by transgenic animals].
    Aoki M; Nagai M; Kato M; Itoyama Y
    No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of amyotrophic lateral sclerosis.
    Robberecht W
    J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis as a complex genetic disease.
    Simpson CL; Al-Chalabi A
    Biochim Biophys Acta; 2006; 1762(11-12):973-85. PubMed ID: 16973338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.
    Valentine JS; Doucette PA; Zittin Potter S
    Annu Rev Biochem; 2005; 74():563-93. PubMed ID: 15952898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOD1 aggregates in ALS: cause, correlate or consequence?
    Brown RH
    Nat Med; 1998 Dec; 4(12):1362-4. PubMed ID: 9846568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.